Jan 152021
 

By Debbie Wright

By Talent4Boards Team Talent4Boards - Great Talent builds Great Boards –  BELGIUM, Mont-Saint-Guibert –  Celyad Oncology SA (EBR: CYAD | NASDAQ: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced the appointment of Dr. Marina Udier, Ph.D. to its Board of Directors. “I am very ... Celyad Oncology welcomes Dr. Marina Udier to its Board of Directors Celyad Oncology welcomes Dr. Marina Udier to its Board of Directors From:: Celyad Oncology welcomes Dr. Marina Udier to its Board of Directors

From:: Celyad Oncology welcomes Dr. Marina Udier to its Board of Directors

      

Sorry, the comment form is closed at this time.